Business Context and Reporting Period
Company: United States Antimony Corporation (UAMY)
Filing Type: Form 8-K (Current Report)
Date of Report: October 17, 2025
Reporting Period: Event date October 17, 2025
The Company filed a prospectus supplement under an automatic shelf registration statement (Form S-3, File No. 333-290901) originally filed on October 16, 2025, which was immediately deemed effective by the SEC.
Key Financial Metrics
This filing is a current report regarding a corporate event and does not contain audited financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics. The filing text does not provide a clear value for these operational financial indicators.
Material Changes and Corporate Actions
- Capital Raise Authorization: The Company registered the offer and sale of up to $400,000,000 of its common stock (par value $0.01 per share).
- Sales Agreement: Offerings will be conducted pursuant to an Amended and Restated Sales Agreement dated September 17, 2025, with A.G.P./Alliance Global Partners and B. Riley Securities, Inc.
- Legal Opinion: An opinion from Duane Morris LLP regarding the validity of the shares is filed as Exhibit 5.1.
Guidance, Outlook, and Risks
Management Commentary: The filing states that this report does not constitute an offer to sell or a solicitation of an offer to buy securities. Sales will only be made via the Prospectus Supplement and are subject to state securities laws.
Risks and Contingencies: The filing notes that no sale of securities will occur in any state where such offer or sale would be unlawful prior to registration or qualification under applicable securities laws.
Investor Verification Checklist
- Verify the terms of the Amended and Restated Sales Agreement dated September 17, 2025, with A.G.P./Alliance Global Partners and B. Riley Securities, Inc.
- Review the full Prospectus Supplement (File No. 333-290901) for specific pricing mechanisms and underwriting fees.
- Confirm the current market price of UAMY common stock to assess the potential dilution impact of a $400 million offering.
- Check for any subsequent filings indicating the actual volume of shares sold under this shelf registration.